Activation of the RNA-dependent protein kinase (PKR) of lymphocytes by regulatory RNAs: Implications for immunomodulation in HIV infection

Current HIV Research

Volumn 3, Issue 4, 2005, Pages 329-337

  Watanabe, Maria Angelica E ^a,b   de Souza, Liliana R ^a   Murad, Joana M ^a   De Lucca, Fernando L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Cytokines; Interferon (IFN ); Noncoding RNAs; Nuclear factor kappa B (NF B); Regulatory RNA; RNA dependent protein kinase (PKR)

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; RNA; SYNTHETIC PEPTIDE;

AMINO TERMINAL SEQUENCE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; EUKARYOTIC CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE; NONHUMAN; PROTEIN DOMAIN; REVIEW; RNA ISOLATION; TRANSCRIPTION REGULATION;

ANIMALS; EIF-2 KINASE; HIV INFECTIONS; HUMANS; LYMPHOCYTES; RNA; RNA, UNTRANSLATED;

EID: 27844589460     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016205774370447     Document Type: Review

References (132)

1. Abraham N, Jaramillo ML, Duncan PI, Méthot N, Icely PL, Stojdl DF, Barber GN, Bell JC. (1998). The murine PKR tumor suppressor gene is rearranged in a lymphocytic leukemia. Experimental Cell Research. 244: 394-404.
2. Almeida R, Allshire RC. (2005). RNA silencing and genome regulation. Trends in Cell Biology. 15: 25-258.
3. Ambros V. (2004). Nature. The functions of animal microRNAs. 431: 350-355.
4. Autran B. (1996). Cytotoxic T-Lymphocyte Response to HIV. In: Gupta S. Ed. Immunology of HIV Infection. New York, Plenum Press. pp. 201-228.
5. Bannwarth S, Gatignol A. (2005). HIV-1 TAR RNA: the target of molecular interactions between the virus and its host. Current HIV Research. 3: 61-71.
6. Barber GN, Wambach M, Thompson S, Jagus R, Katze MG. (1995). Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Molecular and Cellular Biology. 15: 3138-3146.
7. Benito JM, Lopez M, Soriano V. (2004). The role of CD8+ T-cell response in HIV infection. AIDS Reviews. 6: 79-88.
8. Bertolini MC, De Lucca FL. (1986). Poly (A)-containing RNA from the spleens of mice with Chagas' disease triggers in vitro macrophage resistance to Trypanosoma cruzi. Journal of Protozoology. 33: 81-84.
9. Bevilacqua PC, Cech TR. (1996). Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry. 35: 9983-9994.
10. Bevilacqua PC, George CX, Samuel CE, Cech TR. (1998). Binding of the protein kinase PKR to RNAs with secondary structure defects: role of the tandem A-G mismatch and noncontiguous helixes. Biochemistry. 37: 6303-6316.
11. Bhargava PM, Shanmugam G. (1971). Uptake of nonviral nucleic acids by mammalian cells. In: Davidson JN, Cohn, WE Eds, Progress in Nucleic Acid Research and Molecular Biology. New York, Academic Press. pp. 103-192.
12. Boeri E, Gianotti N, Canducci F, Hasson H, Giudici B, Castagna A, Lazzarin A, Clementi M. (2003). Evolutionary characteristics of HIV type 1 variants resistant to protease inhibitors in the absence of drug-selective pressure. AIDS Research and Human Retroviruses. 12: 1151-1153.
13. Bommer UA, Borovjagin AV, Greagg MA, Jeffrey IW, Russell P, Laing KG, Lee M, Clemens MJ. (2002). The mRNA of the translationally controlled tumor protein P23/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR. RNA. 8: 478-496.
14. Brand SR, Kobayashi R, Mathews MB. (1997). The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. The Journal of Biological Chemistry. 13: 8388-8395.
15. + T-cells: Are they Sufficient to Prevent, Contain or Eradicate HIV-1 Infection? Current Drug Targets. Infectious Disorders. 5: 113-119.
16. Cai R, Carpick B, Chun RF, Jeang KT, Williams BRG. (2000). HIV-I Tat inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Archives of Biochemistry and Biophysics. 373: 361-367.
17. Caputo A, Gavioli R, Ensoli B. (2004). Recent advances in the development of HIV-1 Tat-based vaccines. Current HIV Research. 2: 357-376.
18. Castedo M, Perfettini JL, Piacentini M, Kroemer G. (2005). p53-A pro-apoptotic signal transducer involved in AIDS. Biochemical and Biophysical Research Communications. 331: 701-706.
19. Clemens MJ, Elia A. (1997). The double-stranded RNA-dependent protein kinase PKR: structure and function. Journal of Interferon Cytokine Research. 17: 503-524.
20. Clemens MJ. (1997). PKR - a protein kinase regulated by double-stranded RNA. The International Journal of Biochemistry and Cell Biology. 29: 945-949.
21. Clemens MJ. (2003). Interferons and apoptosis. Journal of Interferon Cytokine Research. 23: 277-292.
22. Clemens MJ. (2004). Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene. 23: 3180-3188.
23. Collins KL. (2003). How HIV Evades CTL Recognition. Current HIV Research. 1: 31-40.
24. Cuddihy AR, Wong AH, Tam NW, Li S, Koromilas AE. (1999). The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene. 18: 2690-2702.
25. Davis S, Watson JC. (1996). In vitro activation of the interferon-induced, double-stranded RNA-dependent protein kinase PKR by RNA from the 3′ untranslated regions of human alpha-tropomyosin. Proceedings of the National Academy of Sciences USA. 93: 508-513.
26. DeLuca C, Kwon H, Lin R, Wainberg M, Hiscott J. (1999). NF-kappaB activation and HIV-1 induced apoptosis. Cytokine and Growth Factor Reviews. 10: 235-253.
27. De Lucca FL, Bertolini MC, Zini MN. (1982). In vitro transfer of reactivity to Trypanosoma cruzi antigens from rat cells to human cells with immune RNA. Journal of Infectious Diseases. 45: 148-151.
28. De Lucca FL, Sawan FM, Watanabe MAE, Souza LR. (2001). Effect of the calcium phosphate-mediated RNA uptake on the transfer of cellular immunity of a synthetic peptide of HIV-1 to human lymphocytes by exogenous RNA. Molecular and Cellular Biochemistry. 228: 9-14.
29. De Lucca FL, Sales VSF, Sousa LR, Watanabe MAE. (2002). Evidence for the involvement of the RNA-dependent protein kinase (PKR) in the induction of human cytotoxic T lymphocytes against a synthetic peptide of HIV-1 by regulatory RNA. Molecular and Cellular Biochemistry. 238: 19-26.
30. De Lucca FL, Serrano SV, Souza LR, Watanabe MAE. (2002). Activation of RNA-dependent protein kinase and nuclear factor-kB by regulatory RNA from lipopolysaccharide-stimulated macrophages: implications for cytokine production. European Journal of Pharmacology. 450: 85-89.
31. De Lucca FL, Sales VSF, Sousa LR, Murad JM, Watanabe MAE. (2003). Regulatory RNA induces the production of IFN-gamma, but not IL-4 in human lymphocytes: role of RNA-dependent protein kinase (PKR) and NF-kappaB. Molecular and Cellular Biochemistry. 247: 211-217.
32. Dianzani U, Bensi T, Savanna A, Sametti S, Indelicato M, Mesturini R, Chiocchetti A. (2003). Role of Fas in HIV infection. Current HIV Research. 1: 405-417.
33. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. (2004). Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 303: 1529-1531.
34. + Hematopoietic Stem Cells Inhibits HIV-1 Replication in Differentiated T Cell Progeny. Journal of Interferon and Cytokine Research. 6: 345-360.
35. Donzé O, Deng J, Curran J, Sladek R, Picard D, Sonenberg N. (2004). The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. The EMBO Journal. 23: 564-571.
36. Dray S, Braun DP. (1979). Some perspectives on the transfer of cell-mediated immunity by immune-RNA. Molecular and Cellular Biochemistry. 25: 15-30.
37. Eddy SR. (1999). Noncoding RNA genes. Current Opinion in Genetics Development. 9: 695-699.
38. Eddy SR. (2001). Non-coding RNA genes and the modern RNA world. Nature Reviews Genetics. 2: 919-929.
39. Endo-Munoz L, Warby T, Harrich D, McMillan NA. (2005). Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription. Virology Journal. 2: 17.
40. Erdmann VA, Barciszewska MZ, Hochberg A, de Groot N, Barciszewski J. (2001). Regulatory RNAs. Cellular and Molecular Life Sciences. 58: 960-977.
41. Erdmann VA, Barciszewska MZ, Szymanski M, Hochberg A, de Groot N, Barciszewski J. (2001). The non-coding RNAs as riboregulators. Nucleic Acids Research. 29: 189-193.
42. Feinberg EH, Hunter CP. (2003). Transport of dsRNA into cells by the transmembrane protein SID-1. Science. 301: 1545-1547.
43. Feng GS, Chong K, Kumar A, Williams BRG. (1992). Identification of double-stranded RNA binding domains in interferon-induced double-stranded RNA-activated p68 kinase. Proceedings of the National Academy of Sciences USA. 89: 5447-5451.
44. Fierro-Monti I, Mathews MB. (2000). Proteins binding to duplexed RNA: one motif, multiple functions. Trends in Biochemical Sciences. 255: 241-246.
45. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391: 806-811.
46. Gil J, Alcami J, Esteban M. (1999). Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the alpha subunit of eukaryotic translation initiation factor 2 and NF-kappaB. Molecular and Cellular Biology. 19: 4653-4663.
47. Gil J, Esteban M. (2000). Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis. 5: 107-114.
48. Gil J, Esteban M. (2000). The interferon-induced protein kinase (PKR) triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors. Oncogene. 19: 3665-3674.
49. Gil J, Garcia MA, Esbeban M. (2002). Caspase 9 activation by the dsRNA-dependent protein kinase, PKR: molecular mechanism and relevance. FEBS Letters. 529: 249-255.
50. Gil J, García MA, Gomez-Puertas P, Guerra S, Rullas J, Nakano H, Alcamí J, Esteban M. (2004). TRAF family proteins link PKR with NF-kappa B activation. Molecular and Cellular Biology. 2410: 4502-4512.
51. Goldberg B, Sticker RB. (1999). Apoptosis and HIV infection: T-cells fiddle while the immune system burns. Immunology Letters. 701: 5-8.
52. Gougeon ML, Montagnier L. (1999). Programmed cell death as a mechanism of CD4 and CD8 T cell deletion in AIDS. Molecular control and effect of highly active anti-retroviral therapy. Annals New York Academy of Sciences. 887: 199-212.
53. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, Rosenberg ES, Nguyen T, Allen R, Trocha A, Altfeld M, He S, Bunce M, Funkhouser R, Pelton SI, Burchett SK, McIntosh K, Korber BTM, Walker BD. (2001). Evolution and transmission of stable CTL escape mutations in HIV infection. Nature. 412: 334-338.
54. Goulder PJ, Watkins DI. (2004). HIV and SIV CTL escape: implications for vaccine design. Nature Reviews Immunology. 4: 630-640.
55. Green SR, Mathews MB. (1992). Two RNA binding motifs in the dsRNA-activated protein kinase, DAI. Genes and Development. 6: 2478-2490.
56. Gunnery S, Mathews MB. (1998). RNA binding and modulation of PKR activity. Methods. 15: 189-198.
57. Hanks SK, Hunter T. (1995). Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. The FASEB Journal. 9: 576-596.
58. Hanks SK, Quinn AM, Hunter T. (1988). The protein kinase family: conserved features and deduced phylogeny of catalytic domains. Science. 241: 42-52.
59. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. (2004). Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 303: 1526-1529.
60. Herbein G, Van Lint C, Lovett JL, Verdin E. (1998). Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes. Journal of Virology. 721: 660-670.
61. Hewitt EW, Duban GE. (2004). Virus subversion of protective immunity. Current Allergy and Asthma Reports. 4: 365-370.
62. Huigen MC, Kamp W, Nottet HS. (2004). Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection. European Journal of Clinical Investigation. 34: 57-66.
63. Hüttenhofer A, Schattner P, Polacek N. (2005). Non-coding RNAs: hope or hype? Trends in Genetics. 215: 289-297.
64. Iordanov MS, Ryabinina OP, Schneider P, Magun BE. (2005). Two mechanisms of caspase 9 processing in double-stranded RNA- and virus-triggered apoptosis. Apoptosis. 10: 153-166.
65. Jagus R, Joshi B, Barber GN. (1999). PKR, apoptosis and cancer. The International Journal of Biochemistry and Cell Biology. 31: 123-138.
66. Jarrous N, Osman F, Kaempfer R. (1996). 2-Aminopurine selectively inhibits splicing of tumor necrosis factor alpha mRNA. Molecular and Cellular Biology. 16: 2814-2822.
67. Jiang Z, Zamanian-Daryoush M, Nie H, Silva AM, Williams BR, Li X. (2003). Poly (I-C)-induced Toll-like receptor 3 (TLR3) mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR. The Journal Biological Chemistry. 278: 16713-16719.
68. Kaempfer R. (2003). RNA sensors: novel regulators of gene expression. EMBO Reports. 4: 1043-1047.
69. Kaplan D, Sieg S. (1998). Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1disease. Journal of Virology. 72: 6279-6282.
70. Karin M, Ben-Neriah Y. (2000). Phosphorylation meets ubiquitination: the control of NF-κB activity. Annual Review of Immunology 18: 621-663.
71. Kaufman RJ. (1999). Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor. Proceedings of the National Academy of Science USA. 96: 11693-11695.
72. Kibler KV, Shors T, Perkins KB, Zeman CC, Banaszak MP, Biesterfeldt J, Langland JO, Jacobs BL. (1997). Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells. Journal of Virology. 71: 1992-2003.
73. Kim SH, Forman AP, Mathews MB, Gunnery S. (2000). Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene. 19: 3086-3094.
74. Kim SH, Gunnery S, Choe JK, Mathews MB. (2002). Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR. Oncogene. 21: 8741-8748.
75. Kumar A, Haque J, Lacoste J, Hiscott J, Williams BRG. (1994). Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating I-κB. Proceedings of the National Academy of Sciences USA. 91: 6288-6292.
76. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. (2001). Identification of novel genes coding for small expressed RNAs. Science. 294: 853-858.
77. Lawson VA, Oelrichs R, Guillon C, Imrie AA, Cooper DA, Deacon NJ, McPhee DA. (2002). Adaptive changes after human immunodeficiency virus type 1 transmission. AIDS Research and Human Retroviruses. 8: 545-556.
78. Lee JH, Park EJ, Kim OS, Kim HY, Joe EY, Jou I. (2005). Double-stranded RNA-activated protein kinase is required for the LPS-induced activation of STAT1 inflammatory signaling in rat brain glial cells. Glia. 50: 66-79.
79. Lee RC, Ambros V. (2001). An extensive class of small RNAs in Caenorhabditis elegans. Science. 294: 862-864.
80. Lemckert AA, Goudsmit J, Barouch DH. (2004). Challenges in the search for an HIV vaccine. European Journal of Epidemiology. 19: 513-516.
81. Li J, Petryshyn RA. (1991). Activation of the double-stranded RNA-dependent eIF-2 alpha kinase by cellular RNA from 3T3-F442A cells. European Journal of Biochemistry. 195: 41-48.
82. Li JC, Le DC, Cheung BK, Lau AS. (2005). Mechanisms for HIV Tat upregulation of IL-10 and other cytokine expression: kinase signaling and PKR-mediated immune response. FEBS Letters. 579: 3055-3062.
83. Liang P, Pardee AB. (1992). Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 257: 967-971.
84. + T cells. Genomics. 39: 171-174.
85. Maitra RK, McMillan NA, Desai S, McSwiggen J, Hovanessian AG, Sen G, Williams BR, Silverman RH. (1994). HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology. 204: 823-827.
86. Manche L, Green SR, Schmedt C, Mathews MB. (1992). Interactions between double-stranded RNA regulators and the protein kinase DAI. Molecular and Cellular Biology. 12: 5238-5248.
87. Mattick JS, Gagen MJ. (2001). The evolution of controlled multitasked gene networks: the role of introns and other noncoding RNAs in the development of complex organisms. Molecular Biology Evolution. 18: 1611-1630.
88. Mattick JS. (2001). Non-coding RNAs: the architects of eukaryotic complexity. EMBO Reports. 2: 986-991.
89. Mattick JS. (2004). RNA regulation: a new genetics? Nature Reviews Genetics. 5: 316-323.
90. Mattick JS, Makunin IV. (2005). Small regulatory RNAs in mammals. Human Molecular Genetics. 14: R121-132.
91. McMillan NA, Carpick BW, Hollis B, Toone WM, Zamanian-Daryoush M, Williams BRG. (1995). Mutational analysis of the double-stranded RNA (dsRNA) binding domain of the dsRNA-activated protein kinase, PKR. The Journal of Biological Chemistry. 270: 2601-2606.
92. Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG. (1993). Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proceedings of the National Academy of Sciences USA. 90: 232-236.
93. Michel, U. (2002). Non-coding ribonucleic acids - a class of their own? International Review of Cytology. 218: 143-219.
94. Mitsuhashi S, Saito K, Kurashige S, Yamaguchi N. (1978). Ribonucleic acid in the immune response. Molecular and Cellular Biochemistry. 20: 131-147.
95. Mundschau LJ, Faller DV. (1995). Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR. Immediate early gene induction. The Journal of Biological Chemistry. 270: 3100-3106.
96. Murad JM, Tone LG, de Souza LR, De Lucca FL. (2005). A point mutation in the RNA-binding domain I results in decrease of PKR activation in acute lymphoblastic leukemia. Blood Cells, Molecules and Diseases. 34: 1-5.
97. Nigel AJ, Mcmillan NA, Chun RF, Siderovski DP, Galabru J, Toone WM, Samuel CE, Mak TW, Hovanessian AG, Jeang KT, Williams BRG. (1995). HIV-1 Tat directly interacts with the interferon-induced, double-stranded RNA-dependent kinase, PKR. Virology. 213: 413-424.
98. Nussbaum JM, Gunnery S, Mathews MB. (2002). The 3′-untranslated regions of cytoskeletal muscle mRNAs inhibit translation by activating the double-stranded RNA-dependent protein kinase PKR. Nucleic Acids Research. 30: 1205-1212.
99. Pantaleo G, Koup RA. (2004). Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nature Medicine. 10: 806-810.
100. Paranjape RS. (2005). Immunopathogenesis of HIV infection. The Indian Journal of Medical Research. 1214: 240-255.
101. Passos GAS Jr, De Lucca FL. (1991). RNA-medilited transfer of cellular immunity to a synthetic env antigen of the human immunodeficiency virus (HIV-1). Molecular and Cellular Biochemistry. 108: 1-8.
102. Patel RC, Sen GC. (1992). Identification of dsRNA binding domain of human, interferon-inducible protein kinase. The Journal of Biological Chemistry. 267: 7871-7876.
103. Pilch YH, Ramming KP, DeKernion JB. (1977). Preliminary studies of specific immunotherapy of cancer with immune RNA. Cancer. 40: 2747-2757.
104. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nature Medicine. 5: 518-525.
105. Ratner L. (1996). Genetic Organization of HIV. In: Gupta, S. Ed, Immunology of HIV Infection. New York, Plenum Press, pp 3-22.
106. Ribeiro RA, De Lucca FL, Flares CA, Cunha FQ, Ferreira SH. (1993). RNA from LPS-stimulated macrophages induces the release of tumor necrosis factor α and interleukin-1 by resident macrophages. Mediators of Inflammation. 2: 435-442.
107. Ribeiro RA, Flores CA, Cunha FQ, Ferreira SH, Dc Lucca FL. (1995). Partial characterization of the RNA from LPS-stimulated macrophages that induces the release of chemotactic cytokines by resident macrophages. Molecular and Cellular Biochemistry. 148: 105-113.
108. Richie JP, Wang BS, Steele Jr GD, Wilson RE, Mannick JA. (1981). In vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study. Journal of Urology. 126: 24-28.
109. Richman DD, Wrin T, Little SJ, Petropoulos CJ. (2003). Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proceedings of the National Academy of Sciences USA. 7: 4144-4149.
110. Robertson HD, Mathews MB. (1996). The regulation of the protein kinase PKR by RNA. Biochimie. 78: 909-914.
111. Roulston A, Marcellus RC, Branton PE. (1999). Viruses and apoptosis. Annual Review of Microbiology. 53: 577-628.
112. Savinova O, Joshi B, Jagus R. (1999). Abnormal levels and minimal activity of the dsRNA-activated protein kinase, PKR, in breast carcinoma cells. The International Journal of Biochemistry and Cell Biology. 31: 175-189.
113. Silverman RH. (1994). HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology. 204: 823-827.
114. Srivastava SP, Kumar KU, Kaufman RJ. (1998). Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. The Journal of Biological Chemistry. 273: 2416-2423.
115. Steele G Jr, Wang BS, Mannick JA. (1982). Immune RNA and transfer factor. In: Mihich E. Ed, Immunological Approaches to Cancer Therapeutics. New York, John Wiley and Sons. pp. 257-276.
116. Steele G Jr, Wang BS, Richie JP, Ervin T, Yankee R, Mannick JA. (1982). Results of xenogeneic I-RNA therapy in patients with metastatic renal cell carcinoma. Cancer. 47: 1286-1288.
117. Strebel K. (2003). Virus-host interactions: role of HIV proteins Vif, Tat, and Rev. AIDS. 17: S25-34.
118. Szymanski M, Barciszewski J. (2002). Beyond the proteome: non-coding regulatory RNAs. Genome Biology. 3 (5): reviews 0005.1-0005.8.
119. Takizawa T, Ohashi K, Nakanishi Y. (1996). Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. Journal of Virology. 70: 8128-8132.
120. Takizawa T, Tatematsu C, Nakanishi Y. (1999). Double-stranded RNA-activated protein kinase (PKR) fused to green fluorescent protein induces apoptosis of human embryonic kidney cells: possible role in the Fas signaling pathway. Journal of Biochemistry. 125: 391-398.
121. Tan SL, Katze MG. (1999). The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector: a new face of death? Journal of Interferon and Cytokine Research. 19: 543-554.
122. Taylor DR, Lee SB, Romano PR, Marshak DR, Hinnebusch AG, Esteban M, Mathews MB. (1996). Autophosphorylation sites participate in the activation of the double-stranded-RNA-activated protein kinase PKR. Molecular and Cellular Biology. 11: 6295-6302.
123. Taylor G, Lyall H, Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P. Walker BD, Goulder PJR. (2004). HIV evolution: CTL escape mutation and reversion after transmission. Nature Medicine. 3: 282-289.
124. Thomis DC, Samuel CE. (1992). cDNA structure, expression, and regulation of PKR from human cells. Virology. 188: 33-46.
125. Tian B, Mathews MB. (2001). Functional characterization of and cooperation between the double-stranded RNA-binding motifs of the protein kinase PKR. The Journal of Biological Chemistry. 276: 9936-9944.
126. Watanabe MAE, Almeida DO, Serrano SV, Sales VSF, Soares FA, De Lucca FL. (1997). Immunotherapy of metastases with lymphocytes treated with exogenous RNA in mice bearing B16 melanoma. Cellular and Molecular Biology. 43: 393-398.
127. Watanabe MAE, Souza LR, Murad JM, De Lucca FL. (2003). Antitumor activity induced by regulatory RNA: possible role of RNA-dependent protein kinase and nuclear factor-kappaB. European Journal of Pharmacology. 465: 205-210.
128. Wong AH, Tam NW, Yang YL, Cuddihy AR, Li S, Kirchhoff S, Hauser H, Decker T, Koromilas AE. (1997). Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. The EMBO Journal. 16: 1291-1304.
129. Wong P, Pamer EG. (2003). CD8 T cell responses to infectious pathogens. Annual Review of Immunology. 21: 29-70.
130. Zhang F, Romano PR, Nagamura-Inoue T, Tian B, Dever TE, Mathews MB, Ozato K, Hinnebusch AG. (2001). Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop. The Journal of Biological Chemistry. 276: 24946-24958.
131. Zheng X, Bevilacqua PC. (2000). Straightening of bulged RNA by the double-stranded RNA-binding domain from the protein kinase PKR. Proceedings of the National Academy of Sciences USA. 97: 14162-14167.
132. Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, Pantaleo G. (2005). HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proceedings of the National Academy of Sciences USA. 102: 7239-7244.